Affinity Asset Advisors, LLC 13D/13G Filings for Sutro Biopharma, Inc. (STRO)

Affinity Asset Advisors, LLC 13D and 13G filings for Sutro Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-23
4:07 pm
Purchase
2025-10-1613GSUTRO BIOPHARMA INC
STRO
Affinity Asset Advisors, LLC658,377
7.770%
658,377increase
(New Position)
Filing